Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PLUS: NT 201 in post-stroke lower limb spasticity
NCT01464307Phase 3Completed
- Sponsor
- Merz
- Start
- Dec 2011
- Primary completion
- Aug 2014
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 9
01
Overview
A Phase 3 trial of incobotulinumtoxinA in spasticity, sponsored by Merz. Started Dec 2011; status: completed.
02
Drugs
incobotulinumtoxinA
03
Conditions
spasticity
Beyond the preview
Go deeper on NCT01464307.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01464307.